Alpha-2A adrenergic receptor (α2A-AR)

The alpha‑2A adrenergic receptor is a subtype of G protein-coupled receptors located predominantly on presynaptic nerve terminals within the central nervous system. It serves as a key autoreceptor that mediates negative feedback inhibition of norepinephrine release from sympathetic neurons. By decreasing neurotransmitter output when activated by endogenous catecholamines or pharmacologic agonists such as clonidine or guanfacine,[7] it plays a crucial role in regulating sympathetic tone and maintaining cardiovascular homeostasis. The alpha‑2A subtype is considered the major inhibitory autoreceptor for central noradrenergic transmission; other subtypes like alpha‑2C may also contribute depending on tissue context but are less prominent centrally[7]. Drugs targeting this receptor are used therapeutically for conditions including hypertension,[5] anxiety disorders,[6] attention deficit hyperactivity disorder,[6] pain management,[8] opioid withdrawal symptoms,[5] and sedation during medical procedures.

Other names

Alpha-2 adrenergic receptorα2-adrenergic receptorpresynaptic alpha-2 adrenergic receptorα2A-adrenoceptorcentral alpha-2 adrenergic receptor

Drugs targeting the central presynaptic alpha‑2 adrenergic receptors act primarily as agonists or antagonists. Agonists stimulate these receptors on presynaptic neurons in the CNS—especially in the medulla—leading to decreased norepinephrine release and reduced sympathetic outflow. This results in lowered blood pressure and sedative effects[5][6][7]. Antagonists block this negative feedback loop and can increase norepinephrine release[3].